Pfizer settles trade secrets case with company founded by ex-employees
20 Jul 2023
Patent Infringement
After Pfizer sued a biotech founded by its former employees and accused them of misappropriating trade secrets and breaching contract last year, the companies have now settled.
Attorneys for the two companies filed a two-page document in U.S. District Court for the District of Connecticut on Wednesday, saying the companies had agreed on a settlement. If the court signs off, both Pfizer and Regor Therapeutics will dismiss their claims against each other, and pay their own costs and legal fees. The terms of the settlement were not disclosed.
Preview
Source: EndPoints
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters
SIGN UP
LOG IN
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
-Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.